drugset
drugset / Trial / NCT04075643

Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers

NCT04075643 ↗

Phase 1 Completed 52 enrolled Chong Kun Dang Pharmaceutical
RandomizedCrossoverOpen-labelTreatment

Summary

This study is a randomized, open-label, fasted, single dose, crossover study to evaluate the pharmacokinetic profiles and safety of CKD-385 in healthy volunteers.

Timeline

Start
2019-09-19
Primary completion
2019-09-30
Completion
2019-10-30

Drugs

EvaluationDrugModalityDoseRoute
Subject CKD-385 Unknown — Oral
Subject D935 Unknown — Oral

Indications

cardiovascular disorder